Compare BLKB & FMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLKB | FMC |
|---|---|---|
| Founded | 1981 | 1910 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Major Chemicals |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.0B |
| IPO Year | 2004 | 1994 |
| Metric | BLKB | FMC |
|---|---|---|
| Price | $45.11 | $14.12 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 2 | 13 |
| Target Price | ★ $60.00 | $17.75 |
| AVG Volume (30 Days) | 506.9K | ★ 2.8M |
| Earning Date | 05-13-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 2.25% |
| EPS Growth | ★ 142.32 | N/A |
| EPS | ★ 2.37 | N/A |
| Revenue | N/A | ★ $4,727,800,000.00 |
| Revenue This Year | $7.06 | $8.01 |
| Revenue Next Year | $3.48 | $4.81 |
| P/E Ratio | $19.00 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $44.73 | $12.17 |
| 52 Week High | $74.86 | $44.77 |
| Indicator | BLKB | FMC |
|---|---|---|
| Relative Strength Index (RSI) | 34.53 | 46.43 |
| Support Level | N/A | $12.85 |
| Resistance Level | $64.66 | $14.55 |
| Average True Range (ATR) | 1.72 | 0.75 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 5.31 | 46.69 |
Founded in 1981, Blackbaud provides software solutions designed to serve the "social good" community, including nonprofits, foundations, corporations, educational institutions, healthcare institutions, and individual change agents. Through M&A and organic product development efforts, the company has also moved into related areas outside core fundraising, notably into K-12 schools. The firm enables more than $100 billion in donations annually across a customer base in excess of 40,000 customers in over 100 countries.
FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.